ViroPharma Inc (NASDAQ:VPHM)
During the Trading Day
| 26.10 | +0.24 / +0.93% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 26.10 | |
Volume: 5.8K |
Latest VPHM News | Press Releases
No recent news for ViroPharma Inc.
Today’s Trading
| Previous close | 25.86 |
| Today’s open | 25.87 |
| Day’s range | 25.84 - 26.73 |
| Volume | 1,037,176 |
| Average volume (3 months) | 542,192 |
| Market cap | $1.7B |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | -95.24% |
| Earnings growth (this year) | -1,057.46% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | -21.39% |
| P/E ratio | NM |
| Price/Sales | 3.63 |
| Price/Book | 2.22 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARNAArena Pharmaceutical... | -0.07 | -0.88% |
| MNKDMannkind Corp | +0.87 | +16.23% |
| MDCOThe Medicines Co | -1.18 | -3.50% |
| IRWDIronwood Pharmaceuti... | -0.58 | -4.30% |
Data as of 4:00pm ET, 05/22/2013
Financials
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | $0.03 |
| Annual revenue (last year) | $427.9M |
| Annual profit (last year) | $5.6M |
| Net profit margin | 1.31% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Vincent J. Milano, CPA |
Chief Operating Officer & Vice President Daniel B. Soland |
Corporate headquarters Exton, Pennsylvania |
Forecasts

